Quaker Wealth Management, LLC Neurocrine Biosciences Inc Transaction History
Quaker Wealth Management, LLC
- $268 Million
- Q1 2025
A detailed history of Quaker Wealth Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Quaker Wealth Management, LLC holds 1 shares of NBIX stock, worth $129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$129% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
650Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.83 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.28 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$715 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$628 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$345 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...